Current weight-based r-ATG dosing is empiric at its best and has significant limitations
Emerging clinical outcomes from attempts at individualizing r-ATG dose based on ALC +/- weight-guided r-ATG exposure are quite encouraging and lend credence to further evaluation attempts in the form of large-scale RCTs.
MAT-IN-2300737-v1.0/03/2023